Skip to main content
. 2018 Nov 1;14(14):1960–1973. doi: 10.7150/ijbs.28048

Figure 6.

Figure 6

Serum exosomal MALAT1 levels and their association with poor prognosis in ovarian cancer. (A) MALAT1 expression in serum exosomes from EOC patients and normal controls. (B) Kaplan-Meier survival analysis of patients with high and low levels of serum exosomal MALAT1. (C) A predictive nomogram model for the survival of EOC patients according to clinical characteristics, including serum exosomal MALAT1, FIGO stage and lymph node metastasis. (D) Calibration curve for the 3-year survival in EOC patients. The dashed line shows an ideal nomogram, and the solid line refers to the performance of the actual nomogram. The predicted observations matched the actual observations.